← Open Payments lookup

CECILIA EBOT: Open Payments

NPI 1609571942 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$697 in 29 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $409 · 2025 $697

Food & beverage: $697
CompanyPaymentsAmount
Alkermes, Inc.6$129
ABBVIE INC.4$95
E.R. Squibb & Sons, L.L.C.4$85
Lundbeck LLC3$74
Indivior Inc.2$68
Janssen Pharmaceuticals, Inc1$58
Neurocrine BioSciences, Inc.2$53
Teva Pharmaceuticals USA, Inc.2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Vanda Pharmaceuticals Inc.1$19

Products named: VRAYLAR, COBENFY, ARISTADA, SUBLOCADE, INVEGA SUSTENNA, ABILIFY MAINTENA, INGREZZA, LYBALVI.

Industry payments across MD — which companies pay providers there.